These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32720296)

  • 61. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulatory affairs and biotechnology in Europe. I. Introduction into good regulatory practice.
    Tryzelaar B
    Biotherapy; 1988; 1(1):59-69. PubMed ID: 3079459
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Regulation of the online sale of medical products: experiences and strategies for Latin AmericaRegulamentação da venda de produtos médicos pela internet: experiências e estratégias para a América Latina].
    Rojas-Cortés R; Gorordo M; Vahos J; Galindo Wehdeking R; Saavedra H; Heredia A; Liévano D; Carino J; Sánchez MJ; Castro JL
    Rev Panam Salud Publica; 2023; 47():e81. PubMed ID: 37197594
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Report of the Latin American regional meeting conducted in preparation for the International Conference on Population within the framework of the 7th session of the Committee of High-Level Government Experts].
    Comite de Expertos Gubernamentales de Alto Nivel CEGAN
    Notas Poblacion; 1983 Dec; 11(33):141-64. PubMed ID: 12339527
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Innovation of Medical Products: The Evolution of Regulatory Science, Research, and Education.
    Spindler P; Bach KF; Schmiegelow M; Bedlington N; Eichler HG
    Ther Innov Regul Sci; 2016 Jan; 50(1):44-48. PubMed ID: 30236007
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Can human rights standards help protect children and youth from the detrimental impact of alcohol beverage marketing and promotional activities?
    Chapman AR
    Addiction; 2017 Jan; 112 Suppl 1():117-121. PubMed ID: 27283366
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of regulatory science on global public health.
    Patel M; Miller MA
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S5-9. PubMed ID: 22871603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Latin American and Caribbean regional conference on population and development. Latin American and Caribbean Consensus on Population and Development.
    Latin America and Caribbean Population and Development Conference (1993: Mexico City)
    Popul Bull UN; 1994; (37-38):86-104. PubMed ID: 12287998
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Application of key frameworks to an indicator-based evaluation of environmental health in Latin America and the Caribbean].
    Schütz G; Hacon S; Silva H; Sánchez AR; Nagatani K
    Rev Panam Salud Publica; 2008 Oct; 24(4):276-85. PubMed ID: 19133177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Data Integrity-A Study of Current Regulatory Thinking and Action.
    Shafiei N; De Montardy R; Rivera-Martinez E
    PDA J Pharm Sci Technol; 2015; 69(6):762-70. PubMed ID: 26659106
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Status Update of the Reimbursement Review Environment in the Public Sector across Four Latin American Countries.
    Augustovski F; Diaz Rojas JA; Ferraz MB; Hernandez IC; Korenblat Donato BM; Raimundo K; Asche CV
    Value Health Reg Issues; 2012 Dec; 1(2):223-227. PubMed ID: 29702904
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Establishing a core dossier for multiple regulatory submissions: a case study in the Latin America region.
    Alvarez AL; Maisonet IO; Ruiz O; Lumsden RS; Ferreira APE; Avila Flores EM
    Front Med (Lausanne); 2023; 10():1102452. PubMed ID: 37261120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan.
    Okada K; Koike K; Sawa Y
    Regen Ther; 2015 Jun; 1():80-83. PubMed ID: 31245444
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulatory review: How do agencies ensure the quality of decision making?
    Liberti L; McAuslane N; Patel P; Breckenridge A; Eichler HG; Peterson R
    Clin Pharmacol Ther; 2013 Sep; 94(3):305-8. PubMed ID: 23963218
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional foods: Latin American perspectives.
    Lajolo FM
    Br J Nutr; 2002 Nov; 88 Suppl 2():S145-50. PubMed ID: 12495456
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The invisible force. Midlife and older women.
    Sennott-miller L
    Links; 1993; 9(5):22-3, 29. PubMed ID: 12159275
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Keeping modern in medicine: pharmaceutical promotion and physician education in postwar America.
    Greene JA; Podolsky SH
    Bull Hist Med; 2009; 83(2):331-77. PubMed ID: 19502716
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Analytical Chemistry in the Regulatory Science of Medical Devices.
    Wang Y; Guan A; Wickramasekara S; Phillips KS
    Annu Rev Anal Chem (Palo Alto Calif); 2018 Jun; 11(1):307-327. PubMed ID: 29579404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.